Confidence in Abaxis (ABAX) Shares by Sidoti Fall

Lloyd Doyle
May 17, 2018

25 funds acquired positions and 41 increased positions. Investors holded 21.83 million in 2017Q3 but now own 21.66 million shares or 0.81% less. Millennium Mngmt Limited Liability holds 34,936 shs or 0% of its capital. Northwestern Mutual Wealth Management accumulated 127 shs. California State Teachers Retirement System has invested 0% in Abaxis, Inc. (NASDAQ:ABAX). Ubs Asset Mgmt Americas Inc holds 4,380 shs. PEAK6 Investments L.P. bought a new position in shares of Abaxis in the fourth quarter worth approximately $202,000. (NASDAQ:ABAX). Tudor Corp Et Al holds 0.01% of its capital in Abaxis, Inc. (NASDAQ:ABAX). Stratos Wealth Prns Limited reported 110 shs. Amer Gp Inc owns 17,534 shs. Switzerland-based Swiss Financial Bank has invested 0% in Abaxis, Inc.

If you own shares of Abaxis stock and wish to discuss the legal ramifications of the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. (NASDAQ:ABAX). Glenmede Tru Communication Na reported 88 shares or 0% of all its holdings.

On 7/27/2017 NASDAQ:ABAX - Abaxis announced a quarterly dividend of $0.14 1.19% with an ex dividend date of 8/30/2017 which will be payable on 9/15/2017. This's net activity of $2.85 million. The shares were sold at an average price of $74.33, for a total transaction of $122,644.50. Another trade for 5,000 shares valued at $355,327 was sold by CASEY MICHAEL D. On Tuesday, March 6 ARON KENNETH sold $98,266 worth of Abaxis, Inc. On Tuesday, January 30 the insider SINGH PRITHIPAL sold $149,255.

On 5/8/2018 Achim Henkel, Director, sold 6,000 with an average share price of $68.06 per share and the total transaction amounting to $408,360.00.

Abaxis has a beta of 1.16, indicating that its share price is 16% more volatile than the S&P 500. The all time high was reported by Barchart.com.

Abaxis Inc (NASDAQ:ABAX)'s trailing twelve month revenues are $244.7 Million, whereas its price to sales ratio for the same period is 7.46.

Abaxis Inc
Abaxis Inc

ABAX has a PEG ratio of 4.68, ISR has a PEG ratio of N/A and IRBT has a PEG ratio of 1.49.

On July, 26 WallStreet expected Abaxis, Inc. (NASDAQ:ABAX) or 1,412 shs. Abaxis's revenue for the quarter was up 16.7% compared to the same quarter last year. equities research analysts predict that Abaxis will post 1.44 EPS for the current fiscal year. In case of $0.35 EPS ABAX's profit could reach $7.94 million. As per Zacks simplified descending rating scale the ABR rank is displayed in the range of 1 to 5 where 1 represents Strong Buy and 5 a Strong Sell. $65's average target is -22.01% below currents $83.34 stock price. (NASDAQ:ABAX) shs. $689,851 worth of Abaxis, Inc. Furthermore on 1/26/18 Stifel Nicolaus "Maintained" the stock to Hold at $57. (NASDAQ:ABAX) for 34,936 shares. In Tuesday, January 9 report Northcoast maintained it with "Buy" rating and $72.0 target. On Thursday, January 25 the firm has "Hold" rating given by Stifel Nicolaus.

Sidoti has cut the rating for shares of Abaxis (ABAX) to a solid Neutral in an analyst note sent to investors and clients on 16 May. (NASDAQ:ABAX) earned "Hold" rating by Raymond James. The company was maintained on Friday, January 26 by Stephens.

Abaxis recently launched its new VetScan FLEX4 Rapid Test, which is meant to help detect diseases, such as Heartworm, Lyme, Ehrlichia, and Anaplasma, in dogs.

CEO and Chairman of Abaxis Inc., Clint Severson, has said that the global presence of Zoetis will be able "to deliver greater value to more customers around the world and accelerate the growth of [Abaxis'] worldwide operations". It operates in two divisions, Medical Market and Veterinary Market.76.74 is the P/E ratio. The company offers Piccolo chemistry analyzers with rapid blood constituent measurements for use in human patient care; and Piccolo profiles that are single-use medical reagents.


Other reports by Iphone Fresh

Discuss This Article

FOLLOW OUR NEWSPAPER